Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy

Background: To circumvent possible systemic side effects, anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) for ocular neovascular diseases in adults are approved only for intravitreal administration. However, intravitreal injection itself can elicit injection-related adverse...

Full description

Bibliographic Details

Published in:	Frontiers in Bioscience-Landmark
Main Authors:	Chang Dai, Hong Tian, Amit Bhatt, Guanfang Su, Keith A. Webster, Wei Li
Format:	Article
Language:	English
Published:	IMR Press 2022-04-01
Subjects:	retinopathy of prematurity oxygen-induced retinopathy secretogranin iii scg3 pathological angiogenesis physiological angiogenesis targeted anti-angiogenic therapy
Online Access:	https://www.imrpress.com/journal/FBL/27/4/10.31083/j.fbl2704130